# Investigation of H01 in Adults With Pulmonary Hypertension Including Interstitial Lung Disease (The SATURN Study).

> **NCT05128929** · PHASE2 · COMPLETED · sponsor: **Stanford University** · enrollment: 17 (actual)

## Conditions studied

- Pulmonary Hypertension

## Interventions

- **DRUG:** Hymecromone (H01)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05128929
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-01
- **Primary completion:** 2023-09-21
- **Final completion:** 2023-09-29
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2024-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05128929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05128929, "Investigation of H01 in Adults With Pulmonary Hypertension Including Interstitial Lung Disease (The SATURN Study).". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05128929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*